Pharmacovigilance World 2024
Added: (Sat Mar 30 2024)
Pressbox (Press Release) -
This conference will serve as a knowledge-sharing and networking platform, providing a unique opportunity for researchers, pharmacists, healthcare professionals, industry representatives, and regulatory authorities to come together and discuss the latest trends, challenges, and advancements in pharmacovigilance. By sharing experiences and best practices, we aim to enhance global drug safety and improve patient outcomes. Throughout the conference, we will delve into various topics such as signal detection and management, adverse event reporting and analysis, risk assessment, benefit-risk evaluation, regulatory updates, collaboration and the integration of artificial intelligence and digital technologies in pharmacovigilance.
Our esteemed panel of speakers, comprising leading experts from academia, industry, and regulatory agencies, will present their research findings, share case studies, and engage in thought-provoking discussions. The conference will also feature interactive networking opportunities, fostering collaboration and enabling the exchange of ideas.
We are delighted to welcome you to the Pharmacovigilance World 2024, and we are confident that your active participation will contribute to the advancement of drug safety practices. Together, let us strive towards a safer and more vigilant healthcare system that prioritizes patient well-being and ensures the continued benefit of medications worldwide.
Key Highlights:
Pharmacovigilance and globalization
Pharmacovigilance in a pandemic world
Women and child health care medicines and pharmacovigilance
Patient-centric approaches in PV
Pharmacovigilance legislation and regulations
Harmonization and pharmacovigilance
Advanced therapeutic techniques and pharmacovigilance
Pharmacovigilance and data management and eudravigilance
Post-marketing surveillance in pharmacovigilance
PV regulations and challenges
Benefit-risk management strategies
Risk management and minimization
Risk Evaluation and Mitigation
Adverse drug reactions reporting
Signal detection and post authorization safety
Good Pharmacovigilance Practices
Innovative approaches to drug safety
Strategies to improve PV
Real World Evidence in PV
Big data and AI in pharmacovigilance
Pharmacovigilance Workflows with AI & Automation
Other emerging technologies in PV
Who should attend the conference?
Attendees include GMs, VPs, Directors, Heads and Managers of:
Pharmacovigilance
Safety & Risk management
Drug safety
PV Compliance
Safety Surveillance
Medical Affairs
Regulatory Affairs
Inspection and Audit
Pharmacoepidemiology
Post-market studies
Medical product safety assessment
Drug Research & Development
Clinical Pharmacology
Medical information
Contract outsourcing service providers
Health outcomes
Sales and Marketing